Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subjects: ERN, ERP

Track Group Reports 3rd Quarter Fiscal 2022 Financial Results


NAPERVILLE, Ill., Aug. 10, 2022 /PRNewswire/ -- Track Group, Inc. (OTCQX: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its third quarter ended June 30, 2022 ("Q3 FY22"). In Q3 FY22, the Company posted (i) total revenue of $9.0 million, compared to total revenue for the third quarter ended June 30, 2022 ("Q3 FY21") of $10.3 million; (ii) operating loss of ($0.53 million) compared to Q3 FY21 operating income of $1.3M; and (iii) net loss attributable to common shareholders of ($3.6 million) in Q3 FY22 compared to net income of $1.2 million in Q3 FY21.

"Although a reinvestment in our technology and infrastructure, coupled with supply chain constraints brought on by the pandemic continued to put a damper on our financial results for the third quarter ended June 30, 2022, we anticipate the realization of several preempted strategies in the next sixty to one hundred twenty days which would enable us to increase the manufacturing of new devices, commence implementation of recently awarded programs and support customer growth and demands into FY23," said Derek Cassell, Track Group's CEO.

FINANCIAL HIGHLIGHTS

Business Outlook

The extent to which supply chain delays, the Coronavirus, and the transition to 4G/LTE telecommunications technology impact our future operations will depend on numerous factors that we cannot accurately predict. However, we will not match our results for the fiscal year ended September 2021 ("FY21") in the upcoming year ending September 30, 2022 ("FY22"). Despite these short-term challenges faced by companies worldwide, Track Group remains confident that our continued focus on strategic adaptation, and growth, which evidenced success in FY21, will allow us to be well-positioned for a return to growth in FY23.

About Track Group, Inc.

Track Group designs, manufactures, and markets location tracking devices and develops and sells a variety of related software, services, accessories, networking solutions, and monitoring applications. The Company's products and services are designed to empower professionals in security, law enforcement, corrections, and rehabilitation organizations worldwide with single-sourced offender management solutions that integrate reliable intervention technologies to support re-socialization and monitoring initiatives.

The Company currently trades under the ticker symbol "TRCK" on the OTCQX exchange. For more information, visit www.trackgrp.com

Forward-Looking Statements
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "if", "should" and "will" and similar expressions as they relate to Track Group, Inc., and subsidiaries ("Track Group") are intended to identify such forward-looking statements. These statements are only predictions and reflect Track Group's current beliefs and expectations with respect to future events and are based on assumptions and subject to risks and uncertainties and subject to change at any time. Track Group may from time-to-time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see "Risk Factors" in Track Group's annual report on Form 10-K, its quarterly report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934. New risks emerge from time to time. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

Non-GAAP Financial Measures
This release includes financial measures defined as "non-GAAP financial measures" by the Securities and Exchange Commission including non-GAAP EBITDA. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this

financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with generally accepted accounting principles. Reconciliations of these non-GAAP financial measures are based on the financial figures for the respective period.

Non-GAAP Adjusted EBITDA excludes items including but not limited to interest, taxes, depreciation, amortization, impairment charges, gains and losses, currency effects, one-time charges or benefits that are not indicative of operations, charges to consolidate, integrate or consider recently acquired businesses, costs of closing facilities, stock based or other non-cash compensation or other stated cash and non-cash charges (the "Adjustments").

The Company believes the non-GAAP measures provide useful information to both management and investors when factoring in the Adjustments. Specific disclosure regarding the Company's financial results, including management's analysis of results from operations and financial condition, are contained in the Company's annual report on Form 10-K for the fiscal year ended September 30, 2021, and other reports filed with the Securities and Exchange Commission. Investors are encouraged to carefully read and consider such disclosure and analysis contained in the Company's Form 10-K and other reports, including the risk factors contained in such Form 10-K.

 

TRACK GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS




(Unaudited)

June 30,

2022



September 30,

2021


Assets









Current assets:









Cash


$

4,914,133



$

8,421,162


Accounts receivable, net of allowance for doubtful accounts of $75,995 and $91,262,
respectively



5,430,618




7,163,615


Prepaid expense and deposits



922,060




998,589


Inventory, net of reserves of $0 and $0, respectively



817,772




305,210


Total current assets



12,084,583




16,888,576


Property and equipment, net of accumulated depreciation of $1,830,814 and $2,615,967,
respectively



158,136




202,226


Monitoring equipment, net of accumulated depreciation of $6,425,640 and $5,977,093,
respectively



3,578,188




3,068,100


Intangible assets, net of accumulated amortization of $18,245,022 and $17,607,457,
respectively



18,336,050




20,434,143


Goodwill



8,221,857




8,519,998


Deferred tax asset



-




101,159


Other assets



3,953,193




4,309,040


Total assets


$

46,332,007



$

53,523,242











Liabilities and Stockholders' Equity (Deficit)









Current liabilities:









Accounts payable


$

1,610,734



$

2,821,982


Accrued liabilities



2,358,058




4,350,030


Current portion of long-term debt



474,353




526,134


Total current liabilities



4,443,145




7,698,146


Long-term debt, net of current portion



43,082,508




43,452,216


Long-term liabilities



352,002




3,650


Total liabilities



47,877,655




51,154,012











Commitments and contingencies


















Stockholders' equity (deficit):









Common stock, $0.0001 par value: 30,000,000 shares authorized; 11,863,758 and
11,524,978 shares outstanding, respectively



1,186




1,152


Series A Convertible Preferred stock, $0.0001 par value: 1,200,000 shares authorized; 0
shares outstanding



-




-


Paid in capital



302,324,386




302,250,954


Accumulated deficit



(302,286,667)




(298,828,527)


Accumulated other comprehensive loss



(1,584,553)




(1,054,349)


Total equity (deficit)



(1,545,648)




2,369,230


Total liabilities and stockholders' equity (deficit)


$

46,332,007



$

53,523,242


 

TRACK GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)




(Unaudited)



(Unaudited)




Three Months Ended



Nine Months Ended




June 30,



June 30,



June 30,



June 30,




2022



2021



2022



2021


Revenue:

















Monitoring and other related services


$

8,836,622



$

10,183,133



$

27,148,837



$

29,197,152


Product sales and other



137,460




124,687




905,020




374,403


Total revenue



8,974,082




10,307,820




28,053,857




29,571,555



















Cost of revenue:

















Monitoring, products and other related services



4,200,635




4,150,583




12,284,432




11,752,833


Depreciation and amortization included in cost of revenue



809,234




521,386




2,465,998




1,535,083


Total cost of revenue



5,009,869




4,671,969




14,750,430




13,287,916



















Gross profit



3,964,213




5,635,851




13,303,427




16,283,639



















Operating expense:

















General & administrative



2,734,162




2,868,839




8,003,178




7,583,410


Selling & marketing



778,656




703,014




2,197,237




1,867,880


Research & development



583,492




332,588




1,799,821




974,451


Depreciation & amortization



400,062




434,348




1,231,634




1,476,178


Total operating expense



4,496,372




4,338,789




13,231,870




11,901,919



















Operating income (loss)



(532,159)




1,297,062




71,557




4,381,720



















Other income (expense):

















Interest expense, net



(450,582)




(468,955)




(1,390,318)




(1,674,499)


Currency exchange rate gain (loss)



(750,124)




191,058




(460,033)




1,133,900


Other income (loss), net



(1,593,099)




-




(959,628)




1,000,782


Total other income (expense)



(2,793,805)




(277,897)




(2,809,979)




460,183


Income (loss) before income taxes



(3,325,964)




1,019,165




(2,738,422)




4,841,903


Income tax (benefit) expense



279,095




(178,876)




719,718




136,137


Net income (loss) attributable to common shareholders



(3,605,059)




1,198,041




(3,458,140)




4,705,766


Foreign currency translation adjustments



(527,431)




36,762




(530,204)




89,250


Comprehensive income (loss)


$

(4,132,490)



$

1,234,803



$

(3,988,344)



$

4,795,016


Net income/(loss) per share ? basic:

















Net income (loss) per share


$

(0.31)



$

0.10



$

(0.30)



$

0.41


Weighted average shares outstanding



11,566,869




11,460,694




11,546,673




11,436,609


Net income (loss) per share ? diluted:

















Net income (loss) per share


$

(0.31)



$

0.10



$

(0.30)



$

0.39


Weighted average shares outstanding



11,566,869




12,015,742




11,546,673




12,051,679


 

TRACK GROUP, INC. AND SUBSIDIARIES
NON-GAAP ADJUSTED EBITDA MARCH 31 (UNAUDITED)
(amounts in thousands, except share and per share data)




Three Months Ended

June 30,



Nine Months Ended

June 30,




2022



2021



2022



2021



















Non-GAAP Adjusted EBITDA

















Net income (loss) attributable to common shareholders


$

(3,605)



$

1,198



$

(3,458)



$

4,706


Interest expense, net



450




468




1,390




1,674


Depreciation and amortization



1,210




955




3,698




3,011


Income taxes (1)



279




(179)




720




136


Board compensation and stock-based compensation



169




75




319




225


Foreign exchange expense



750




(191)




460




(1,001)


Loan forgiveness



-




-




-




(1,134)


Settlement of litigation



1,600




-




1,600




-


Gain on forgiveness of accrued vendor expenses



-




-




(633)




-


Other charges, net (2)



478




476




1,170




709


Non GAAP Adjusted EBITDA


$

1,331



$

2,802



$

5,266



$

8,326


Non GAAP Adjusted EBITDA, percent of revenue



14.8

%



27.2

%



18.8

%



28.2

%


















Non-GAAP earnings per share - Basic

















Weighted average common shares outstanding



11,566,869




11,460,694




11,546,673




11,436,609


Non-GAAP earnings per share


$

0.12



$

0.24



$

0.46



$

0.73



















Non-GAAP earnings per share - Diluted

















Weighted average common shares outstanding



11,566,869




12,015,742




11,546,673




12,051,679


Non-GAAP earnings per share


$

0.12



$

0.23



$

0.46



$

0.69




(1)

Currently, the Company has significant U.S. tax loss carryforwards that may be used to offset future taxable income, subject
to IRS limitations. However, the Company is still subject to certain state, commonwealth, and other foreign based taxes.



(2)

Other charges may include gains or losses and non-recurring accrual adjustments.

 

SOURCE Track Group, Inc.


These press releases may also interest you

at 03:05
Vagaro, the leading international salon and spa software, and Jack Mead, award-winning hair stylist, salon owner, and educator, officially announced the release of their highly-anticipated Master Class series, delivering expert insights on using the...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...



News published on and distributed by: